HOME › DRUGS › WARFARIN SODIUM
ACTIVE SUBSTANCE / INN

WARFARIN SODIUM

Brand name(s): PANWARFIN, ATHROMBIN, WARFARIN SODIUM, COUMADIN, JANTOVEN
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA017020
NDA009218
ACTIVE SUBSTANCE
Warfarin Sodium
REGULATORS
FDA
SPONSORS / MAH
UPSHER SMITH LABS, BRISTOL MYERS SQUIBB, INVAGEN PHARMS
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
WARFARIN SODIUMANDA200104AIPING PHARM INCDiscontinued
WARFARIN SODIUMANDA090935INVAGEN PHARMSPrescription
ATHROMBINNDA011771PHARM RES ASSOCDiscontinued
JANTOVENANDA040416UPSHER SMITH LABSPrescription
COUMADINNDA009218BRISTOL MYERS SQUIBBDiscontinued
PANWARFINNDA017020ABBOTTDiscontinued

FULL INTELLIGENCE ON WARFARIN SODIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →